Evidence map›Paper›PMID 39711786›Full record

SynthesisFrontiers in neurology2024

Paroxysmal extreme pain disorder associated with a mutation in SCN9A gene - Case report and own experiences.

Mateusz Szczupak, Jolanta Wierzchowska, Maria Cimoszko-Zauliczna, Jacek Kobak, Justyna Kosydar-Bochenek, Wojciech Radys, Agnieszka Szlagatys-Sidorkiewicz, Dorota Religa, Sabina Krupa-Nurcek

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Progress in pain mechanisms and management.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mateusz SzczupakDepartment of Anesthesiology and Intensive Care, Copernicus Hospital in Gdańsk, Gdańsk, Poland.
Jolanta WierzchowskaDepartment of Anesthesiology and Intensive Care, Copernicus Hospital in Gdańsk, Gdańsk, Poland.
Maria Cimoszko-ZaulicznaDepartment of Anesthesiology and Intensive Care, Copernicus Hospital in Gdańsk, Gdańsk, Poland.
Jacek KobakDepartment of Otolaryngology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
Justyna Kosydar-BochenekInstitute of Health Sciences, College of Medical Sciences of the University of Rzeszów, Rzeszów, Poland.
Wojciech RadysDepartment of Gastroenterology, Allergology and Child Nutrition, Medical University of Gdańsk, Gdańsk, Poland.
Agnieszka Szlagatys-SidorkiewiczDepartment of Gastroenterology, Allergology and Child Nutrition, Medical University of Gdańsk, Gdańsk, Poland.
Dorota ReligaDepartment of Neurobiology, Care Science and Society (NVS), I Karolinska Institute, Stockholm, Sweden.
Sabina Krupa-NurcekDepartment of Surgery, Institute of Medical Sciences, Medical College of Rzeszów University, Rzeszów, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pain is an unpleasant sensory and emotional experience, influenced by various factors. Paroxysmal extreme pain disorder (PEPD) is a rare genetic condition characterized by sudden bouts of pain accompanied by autonomic symptoms. Material methods and aim: This manuscript presents the case of a 9-year-old boy with paroxysmal extreme pain syndrome and provides a review of the literature. Additionally, a genealogical analysis of the boy's family was conducted to determine the total number of affected family members. The clinical data included an analysis of genetic tests to identify the mutation confirming PEPD. Result and conclusion: A mutation in the SCN9A gene causes the disease, and due to the small number of patients worldwide (around 500, according to literature reports), an effective method of preventing extreme pain attacks had not been established at the time of writing this manuscript. Based on information from scientific sources and the authors' experiences, it can be firmly stated that various, often difficult-to-identify factors cause paroxysmal extreme pain. This syndrome necessitates further research and the exploration of effective treatment methods.

Indexed as

chronic paingenetic variabilitypainparoxysmal extreme pain syndromeSCN9A gene

Identifiers

PMID39711786
PMCPMC11659239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.